Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.25p
   
  • Change Today:
    -0.050p
  • 52 Week High: 4.15
  • 52 Week Low: 0.95
  • Currency: UK Pounds
  • Shares Issued: 135.47m
  • Volume: 211,800
  • Market Cap: £1.69m
  • RiskGrade: 504

Deal with Barclays    Trade now with Barclays Stockbrokers

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -96.0% -52.9%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.9 2.2
Pr/Book 3.3  
Latest F'cast
Revenue -28.1% 42.3%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 0.72 (0.20) (0.14)p n/a n/a n/a n/a 0.0%
30-Jun-20 0.80 (0.13) (0.09)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 0.85 (0.45) (0.25)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Physiomics Company Announcements

Contract Award 18-Mar-2024 07:00 RNS
Interim Results 07-Mar-2024 07:00 RNS
Options Award 06-Feb-2024 07:00 RNS

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 1.25p
Change Today -0.050p
% Change -3.85 %
52 Week High 4.15
52 Week Low 0.95
Volume 211,800
Shares Issued 135.47m
Market Cap £1.69m
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.03% below the market average31.03% below the market average31.03% below the market average31.03% below the market average31.03% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Price Trend
83.54% below the market average83.54% below the market average83.54% below the market average83.54% below the market average83.54% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average
Income Not Available
Growth
59.43% below the market average59.43% below the market average59.43% below the market average59.43% below the market average59.43% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Physiomics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
12:25 48,096 @ 1.33p
10:12 2,778 @ 1.22p
10:10 100,000 @ 1.22p
09:43 7,707 @ 1.22p

Physiomics Key Personnel

COO Christophe Chassagnole
CEO Peter Sargent

Top of Page